This release contains sample information and accession numbers, analysis BAMs, and de novo variant discovery and genotyping across 2,512 samples collected in 14 countries, as well as five lab strains included for method development validation.
At the time of their release, these data were subject to the Pf3k Pilot Phase Terms of Use. In September 2016, these restrictions were lifted and this dataset is now available open access.